LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 12 of 15: Mean cell count and mean normalized growth rate inhibition values across biological replicate 2. - Dataset (ID:20249)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|---|
Hs 578T | SNS-032 | 3.33 | uM | LJP6 | 72 | hr | 765 | 431 | 3101 | 0.1389 | -0.2475 |
Hs 578T | SNS-032 | 10 | uM | LJP6 | 72 | hr | 765 | 399 | 3101 | 0.1289 | -0.2751 |
Hs 578T | Afatinib | 0.04 | uM | LJP6 | 72 | hr | 765 | 2933 | 3101 | 0.9455 | 0.9451 |
Hs 578T | Afatinib | 0.12 | uM | LJP6 | 72 | hr | 765 | 2876 | 3101 | 0.9273 | 0.9266 |
Hs 578T | Afatinib | 0.37 | uM | LJP6 | 72 | hr | 765 | 2883 | 3101 | 0.9295 | 0.9285 |
Hs 578T | Afatinib | 1.11 | uM | LJP6 | 72 | hr | 765 | 2709 | 3101 | 0.8734 | 0.8702 |
Hs 578T | Afatinib | 3.33 | uM | LJP6 | 72 | hr | 765 | 2529 | 3101 | 0.8157 | 0.8080 |
Hs 578T | Afatinib | 10 | uM | LJP6 | 72 | hr | 765 | 491 | 3101 | 0.1583 | -0.1974 |
Hs 578T | GSK1904529A | 0.04 | uM | LJP6 | 72 | hr | 765 | 2985 | 3101 | 0.9626 | 0.9626 |
Hs 578T | GSK1904529A | 0.12 | uM | LJP6 | 72 | hr | 765 | 2929 | 3101 | 0.9447 | 0.9445 |
Hs 578T | GSK1904529A | 0.37 | uM | LJP6 | 72 | hr | 765 | 3046 | 3101 | 0.9819 | 0.9818 |
Hs 578T | GSK1904529A | 1.11 | uM | LJP6 | 72 | hr | 765 | 2842 | 3101 | 0.9163 | 0.9150 |
Hs 578T | GSK1904529A | 3.33 | uM | LJP6 | 72 | hr | 765 | 2849 | 3101 | 0.9186 | 0.9174 |
Hs 578T | GSK1904529A | 10 | uM | LJP6 | 72 | hr | 765 | 2905 | 3101 | 0.9364 | 0.9356 |
Hs 578T | Linsitinib | 0.04 | uM | LJP5 | 72 | hr | 765 | 3175 | 3148 | 1.0087 | 1.0084 |
Hs 578T | Linsitinib | 0.12 | uM | LJP5 | 72 | hr | 765 | 3166 | 3148 | 1.0059 | 1.0057 |
Hs 578T | Linsitinib | 0.37 | uM | LJP5 | 72 | hr | 765 | 2997 | 3148 | 0.9521 | 0.9523 |
Hs 578T | Linsitinib | 1.11 | uM | LJP5 | 72 | hr | 765 | 3223 | 3148 | 1.0238 | 1.0230 |
Hs 578T | Linsitinib | 3.33 | uM | LJP5 | 72 | hr | 765 | 3097 | 3148 | 0.9840 | 0.9842 |
Hs 578T | Linsitinib | 10 | uM | LJP5 | 72 | hr | 765 | 2514 | 3148 | 0.7987 | 0.7912 |
Hs 578T | Ruxolitinib | 0.04 | uM | LJP5 | 72 | hr | 765 | 3133 | 3148 | 0.9952 | 0.9953 |
Hs 578T | Ruxolitinib | 0.12 | uM | LJP5 | 72 | hr | 765 | 3194 | 3148 | 1.0146 | 1.0142 |
Hs 578T | Ruxolitinib | 0.37 | uM | LJP5 | 72 | hr | 765 | 3131 | 3148 | 0.9946 | 0.9946 |
Hs 578T | Ruxolitinib | 1.11 | uM | LJP5 | 72 | hr | 765 | 3003 | 3148 | 0.9541 | 0.9545 |
Hs 578T | Ruxolitinib | 3.33 | uM | LJP5 | 72 | hr | 765 | 2778 | 3148 | 0.8826 | 0.8811 |